Literature DB >> 33029742

Red Cell Distribution Width as a Marker of Periprocedural Myocardial Infarction in Patients with Elective Percutaneous Coronary Intervention.

Chunfeng Dai1, Zhangwei Chen1, Juying Qian2, Junbo Ge1.   

Abstract

We aimed to investigate whether red cell distribution width (RDW) was associated with periprocedural myocardial infarction (PMI) in patients undergoing elective percutaneous coronary intervention (PCI). Among 1723 consecutive patients undergoing elective PCI, a total of 230 (13.3%) met the diagnostic criteria of PMI. The high RDW (≥ 12.6%) group tended to have PMI (15.4% vs. 11.2%, P = 0.010). RDW was an independent predictor of PMI whether as a categorical variable (adjusted odds ratio = 1.442, 95% confidence interval = 1.088 to 1.911, P = 0.011) or a continuous variable (adjusted odds ratio = 1.236, 95% confidence interval = 1.079 to 1.415, P = 0.002). High RDW was also significantly associated with increased risk of major adverse cardiovascular events (MACE) during follow-up. However, anemia was not independently associated with PMI or MACE in the current study. In conclusion, RDW showed strong and independent association with PMI in patients undergoing elective PCI.

Entities:  

Keywords:  Percutaneous coronary intervention; Periprocedural myocardial infarction; Red cell distribution width

Mesh:

Substances:

Year:  2020        PMID: 33029742     DOI: 10.1007/s12265-020-10073-w

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  1 in total

1.  Incorporation of Laboratory Test Biomarkers Into Dual Antiplatelet Therapy Score Improves Prediction of Ischemic and Bleeding Events in Post-percutaneous Coronary Intervention Patients.

Authors:  Chengming Sun; Lin Zhong; Yanqiu Wu; Chengfu Cao; Danjie Guo; Jie Liu; Lei Gong; Shouxin Zhang; Jun Sun; Yingqi Yu; Weiwei Tong; Jun Yang
Journal:  Front Cardiovasc Med       Date:  2022-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.